The Clinical Relevance of Noncriteria Antiphospholipid Antibodies

Seminars in Thrombosis and Hemostasis

Volumn 44, Issue 5, 2018, Pages 453-457

  Bertolaccini, Maria Laura ^a   Sanna, Giovanni ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

coagulation; lupus; phosphatidylserine; prothrombin; thrombotic risk; 2 GPI

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A; LUPUS ANTICOAGULANT; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID ANTIBODY;

AMINO TERMINAL SEQUENCE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HIGH RISK PATIENT; HUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN DOMAIN; RISK ASSESSMENT; BLOOD; FEMALE; IMMUNOLOGY; PREGNANCY;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; PREGNANCY;

EID: 85038824212     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0037-1601328     Document Type: Article

References (58)

1. Miyakis S. Lockshin M. D. Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost: 2006; 4 02 295 306
2. Forastiero R. Papalardo E. Watkins M., et al. Evaluation of different immunoassays for the detection of antiphospholipid antibodies: report of a wet workshop during the 13th International Congress on Antiphospholipid Antibodies. Clin Chim Acta: 2014; 428 99 105
3. Pierangeli S. S. Harris E. N. A protocol for determination of anticardiolipin antibodies by ELISA. Nat Protoc: 2008; 3 05 840 848
4. Pengo V. Tripodi A. Reber G., et al. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost: 2009; 7 10 1737 1740
5. Lakos G. Favaloro E. J. Harris E. N., et al. International consensus guidelines on anticardiolipin and anti-b2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies. Arthritis Rheum: 2012; 64 01 1 10
6. Devreese K. M. Pierangeli S. S. de Laat B. Tripodi A. Atsumi T. Ortel T. L.; Subcommittee on Lupus Anticoagulant/Phospholipid/Dependent Antibodies. Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH. J Thromb Haemost: 2014; 12 05 792 795
7. Moore G. W. Recent guidelines and recommendations for laboratory detection of lupus anticoagulants. Semin Thromb Hemost: 2014; 40 02 163 171
8. Hughes G. R. Khamashta M. A. Seronegative antiphospholipid syndrome. Ann Rheum Dis: 2003; 62 12 1127
9. Bertolaccini M. L. Hughes G. R. Khamashta M. A. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins. Clin Lab: 2004; 50 (11-12): 653 665
10. Bertolaccini M. L. Atsumi T. Koike T. Hughes G. R. Khamashta M. A. Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb Haemost: 2005; 93 02 289 297
11. Galli M. Luciani D. Bertolini G. Barbui T. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood: 2003; 102 08 2717 2723
12. Funke A. Bertolaccini M. L. Atsumi T. Amengual O. Khamashta M. A. Hughes GR V. Autoantibodies to prothrombin-phosphatidylserine complex: clinical significance in systemic lupus erythematosus. (abstract) Arthritis Rheum: 1998; 41 S240
13. Atsumi T. Ieko M. Bertolaccini M. L., et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum: 2000; 43 09 1982 1993
14. Bertolaccini M. L. Gomez S. Pareja J. F., et al. Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis: 2005; 64 11 1639 1643
15. Sciascia S. Murru V. Sanna G. Roccatello D. Khamashta M. A. Bertolaccini M. L. Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities. J Thromb Haemost: 2012; 10 12 2512 2518
16. Sciascia S. Sanna G. Murru V. Roccatello D. Khamashta M. A. Bertolaccini M. L. Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. Thromb Haemost: 2014; 111 02 354 364
17. Pregnolato F. Chighizola C. B. Encabo S., et al. Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS? Immunol Res: 2013; 56 (2-3): 432 438
18. Bertolaccini M. L. Sciascia S. Murru V. Garcia-Fernandez C. Sanna G. Khamashta M. A. Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant. Thromb Haemost: 2013; 109 02 207 213
19. Iverson G. M. Reddel S. Victoria E. J., et al. Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies. J Immunol: 2002; 169 12 7097 7103
20. de Laat B. de Groot P. G. Autoantibodies directed against domain I of beta2-glycoprotein I. Curr Rheumatol Rep: 2011; 13 01 70 76
21. Iverson G. M. Victoria E. J. Marquis D. M. Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI. Proc Natl Acad Sci U S A: 1998; 95 26 15542 15546
22. Reddel S. W. Wang Y. X. Sheng Y. H. Krilis S. A. Epitope studies with anti-beta 2-glycoprotein I antibodies from autoantibody and immunized sources. J Autoimmun: 2000; 15 02 91 96
23. de Laat B. Derksen R. H. Urbanus R. T. de Groot P. G. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood: 2005; 105 04 1540 1545
24. de Laat B. Pengo V. Pabinger I., et al. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost: 2009; 7 11 1767 1773
25. Banzato A. Pozzi N. Frasson R., et al. Antibodies to domain I of b(2)glycoprotein I are in close relation to patients risk categories in antiphospholipid syndrome (APS). Thromb Res: 2011; 128 06 583 586
26. Pericleous C. Ferreira I. Borghi O., et al. Measuring IgA anti-b2-glycoprotein I and IgG/IgA anti-domain I antibodies adds value to current serological assays for the antiphospholipid syndrome. PLoS One: 2016; 11 06 e0156407
27. Mahler M. Albesa R. Zohoury N., et al. Autoantibodies to domain 1 of beta 2 glycoprotein I determined using a novel chemiluminescence immunoassay demonstrate association with thrombosis in patients with antiphospholipid syndrome. Lupus: 2016; 25 08 911 916
28. 2 -glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile? Ann Rheum Dis: 2011; 70 02 380 383
29. Arvieux J. Renaudineau Y. Mane I. Perraut R. Krilis S. A. Youinou P. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. Thromb Haemost: 2002; 87 04 599 605
30. Avcin T. Ambrozic A. Kuhar M. Kveder T. Rozman B. Anticardiolipin and anti-beta(2) glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology (Oxford): 2001; 40 05 565 573
31. Ambrozic A. Avicin T. Ichikawa K., et al. Anti-beta(2)-glycoprotein I antibodies in children with atopic dermatitis. Int Immunol: 2002; 14 07 823 830
32. Andreoli L. Chighizola C. B. Nalli C., et al. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against b2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome. Arthritis Rheumatol: 2015; 67 08 2196 2204
33. Sanmarco M. Gayet S. Alessi M. C., et al. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies. Thromb Haemost: 2007; 97 06 949 954
34. Bertolaccini M. L. Murru V. Sciascia S. Sanna G. Khamashta M. A. The clinical value of testing for antibodies to phosphatidylethanolamine (aPE) in patients with systemic lupus erythematosus (SLE). Thromb Res: 2012; 130 06 914 918
35. Staub H. L. Bertolaccini M. L. Khamashta M. A. Anti-phosphatidylethanolamine antibody, thromboembolic events and the antiphospholipid syndrome. Autoimmun Rev: 2012; 12 02 230 234
36. Kaburaki J. Kuwana M. Yamamoto M. Kawai S. Ikeda Y. Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. Am J Hematol: 1997; 54 03 209 213
37. Rand J. H. Wu X. X. Andree HA M., et al. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med: 1997; 337 03 154 160
38. Sugi T. McIntyre J. A. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood: 1995; 86 08 3083 3089
39. Sugi T. McIntyre J. A. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens. J Autoimmun: 2001; 17 03 207 214
40. Shibata S. Sasaki T. Harpel P. Fillit H. Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes. Clin Immunol Immunopathol: 1994; 70 02 114 123
41. Shibata S. Harpel P. C. Gharavi A. Rand J. Fillit H. Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes. Blood: 1994; 83 09 2532 2540
42. Jones D. W. Gallimore M. J. Harris S. L. Winter M. Antibodies to factor XII associated with lupus anticoagulant. Thromb Haemost: 1999; 81 03 387 390
43. Jones D. W. Gallimore M. J. MacKie I. J. Harris S. L. Winter M. Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII. Br J Haematol: 2000; 110 03 721 726
44. Jones D. W. MacKie I. J. Gallimore M. J. Winter M. Antibodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome. Br J Haematol: 2001; 113 02 550 552
45. Hwang K. K. Grossman J. M. Visvanathan S., et al. Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin. J Immunol: 2001; 167 12 7192 7198
46. Oosting J. D. Derksen R. H. Bobbink I. W. Hackeng T. M. Bouma B. N. de Groot P. G. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood: 1993; 81 10 2618 2625
47. Atsumi T. Khamashta M. A. Amengual O., et al. Binding of anticardiolipin antibodies to protein C via beta2-glycoprotein I (beta2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system. Clin Exp Immunol: 1998; 112 02 325 333
48. Erkan D. Zhang H. W. Shriky R. C. Merrill J. T. Dual antibody reactivity to beta2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome. Lupus: 2002; 11 04 215 220
49. Bertolaccini M. L. Sanna G. Ralhan S., et al. Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance. Thromb Haemost: 2003; 90 04 636 641
50. Carson C. W. Comp P. C. Esmon N. L. Rezaie A. R. Esmon C. T. Thrombomodulin antibodies inhibit protein C activation and are found in patients with lupus anticoagulant and unexplained thrombosis. (abstract) Arthritis Rheum: 1994; 37 S296
51. Molina J. F. Gutierrez-Ureña S. Molina J., et al. Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus. J Rheumatol: 1997; 24 02 291 296
52. Diri E. Cucurull E. Gharavi A. E., et al. Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and abeta2 glycoprotein-I is the most frequent isotype. Lupus: 1999; 8 04 263 268
53. Bertolaccini M. L. Atsumi T. Escudero Contreras A. Khamashta M. A. Hughes GR V. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. J Rheumatol: 2001; 28 12 2637 2643
54. Meijide H. Sciascia S. Sanna G. Khamashta M. A. Bertolaccini M. L. The clinical relevance of IgA anticardiolipin and IgA anti-b2 glycoprotein I antiphospholipid antibodies: a systematic review. Autoimmun Rev: 2013; 12 03 421 425
55. Fanopoulos D. Teodorescu M. R. Varga J. Teodorescu M. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. J Rheumatol: 1998; 25 04 675 680
56. Lee R. M. Branch D. W. Silver R. M. Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death. Am J Obstet Gynecol: 2001; 185 03 748 753
57. Kumar S. Papalardo E. Sunkureddi P. Najam S. González E. B. Pierangeli S. S. Isolated elevation of IgA anti-beta2glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients. Lupus: 2009; 18 11 1011 1014
58. Morales J. M. Serrano M. Martínez-Flores J. A., et al. The presence of pretransplant antiphospholipid antibodies IgA anti-b-2-glycoprotein I as a predictor of graft thrombosis after renal transplantation. Transplantation: 2017; 101 03 597 607